Baystate Wealth Management’s Leap Therapeutics LPTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | $14.3K | Buy |
3,441
+1,903
| +124% | +$7.89K | ﹤0.01% | 645 |
|
2023
Q3 | $2.12K | Hold |
1,538
| – | – | ﹤0.01% | 793 |
|
2023
Q2 | $4.81K | Sell |
1,538
-1
| -0.1% | -$3 | ﹤0.01% | 706 |
|
2023
Q1 | $5.23K | Hold |
1,539
| – | – | ﹤0.01% | 683 |
|
2022
Q4 | $7K | Hold |
1,539
| – | – | ﹤0.01% | 646 |
|
2022
Q3 | $14K | Hold |
1,539
| – | – | ﹤0.01% | 491 |
|
2022
Q2 | $18K | Hold |
1,539
| – | – | ﹤0.01% | 465 |
|
2022
Q1 | $27K | Hold |
1,539
| – | – | ﹤0.01% | 407 |
|
2021
Q4 | $50K | Hold |
1,539
| – | – | ﹤0.01% | 324 |
|
2021
Q3 | $62K | Buy |
+1,539
| New | +$62K | 0.01% | 272 |
|